Eli Lilly has filed six new lawsuits against U.S. entities that it alleges are selling a version of the company’s investigational weight-loss drug on the black market.
An experimental oral GLP-1 pill matched injection-level weight loss in an early trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results